Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandins for first-trimester termination.

Karen R Meckstroth1, Philip D Darney

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco General Hospital, San Francisco, CA 94110, USA. meckstrothk@obgyn.ucsf.edu

Best Practice & Research. Clinical Obstetrics & Gynaecology
|September 16, 2003
PubMed
Summary

Medical abortion using mifepristone and misoprostol is safe and effective. Evidence supports refined regimens, including vaginal misoprostol and home self-administration, with minimal contraindications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"No Big Deal": A Qualitative Study of Pharmacists' Perspectives on Dispensing Mifepristone for Medication Abortion.

Women's health issues : official publication of the Jacobs Institute of Women's Health·2022
Same author

Roe 2022: It's Not 1972.

Obstetrics and gynecology·2022
Same author

Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic.

JAMA network open·2021
Same author

Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion.

Journal of the American Pharmacists Association : JAPhA·2021
Same author

Medication Abortion With Pharmacist Dispensing of Mifepristone.

Obstetrics and gynecology·2021
Same author

Intrauterine Devices and Sexually Transmitted Infection among Older Adolescents and Young Adults in a Cluster Randomized Trial.

Journal of pediatric and adolescent gynecology·2020

Area of Science:

  • Reproductive Health
  • Pharmacology

Background:

  • Medical abortion, initially established with mifepristone and prostaglandins in the 1980s, has seen significant advancements.
  • Alternative regimens, including methotrexate and misoprostol, have been explored to optimize early abortion care.

Purpose of the Study:

  • To review and synthesize current evidence on medical abortion regimens.
  • To evaluate the efficacy and safety of different drug combinations and administration routes.
  • To identify optimal practices for medical abortion, including self-administration.

Main Methods:

  • Systematic review of studies on medical abortion.
  • Analysis of data on mifepristone dosage, misoprostol routes (oral, vaginal, buccal, sublingual), and gestational age.
  • Assessment of contraindications and side effects associated with medical abortion.

Related Experiment Videos

Main Results:

  • Doses of mifepristone exceeding 200 mg offer no additional benefit.
  • Vaginal misoprostol is more effective than oral administration, particularly between 7-9 weeks of gestation.
  • Misoprostol can be safely self-administered at home; buccal and sublingual routes show promise.

Conclusions:

  • Current evidence supports refined medical abortion protocols, enhancing safety and efficacy.
  • Vaginal misoprostol and home self-administration represent significant advancements in early abortion care.
  • Careful patient assessment remains crucial for successful medical abortion outcomes.